| Health / Medical Topics |
MUC-1 Peptide Vaccine
A cancer vaccine comprised of a synthetic peptide derived from the mucin 1 (MUC1) antigen with potential antineoplastic activity. Upon administration, MUC1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the MUC1 antigen, resulting in decreased tumor growth. Overexpressed on many tumor cells, MUC1 antigen, a mammary-type apomucin, is a high-molecular-weight transmembrane glycoprotein. (NCI Thesaurus)
YOU MAY ALSO LIKE
MUC-1 antigen is a mammary-type apomucin, a high molecular weight transmembrane glycoprotein, of which the extracellular domain is formed by a repeating…
A protein found on certain epithelial cells, which line the inside and outside surfaces of the body. It may be found in…
A clonal disorder characterized by the secretion of a mu heavy chain that lacks a variable region. Most patients present with…
The determination of the ratio of mu glutathione-s-transferase compared to creatinine present in a sample. The measurement may be expressed as a…
The determination of the amount of mu glutathione-s-transferase present in a sample.
A drug used to treat some types of cancer, rheumatoid arthritis, and severe skin conditions, such as psoriasis. MTX stops cells from…
